Kawasaki disease: 40 years after the original report.
The cause of Kawasaki disease (KD) remains unknown, although a number of epidemiologic and clinical observations suggest it is triggered by one or more infectious agents, each of which can result in the clinical manifestation of the disease. Advances have been made in the management of the disease with the introduction of aspirin and intravenous immunoglobulin (IVIG), which have had a significant impact on lowering the rate of coronary artery aneurysms and death from the disease. Questions remain regarding the management of those patients who fail to respond to IVIG. It appears that some patients with severe KD who are resistant to IVIG may benefit from IV pulse steroid therapy or infliximab infusion. However, a recent multicenter, randomized, controlled trial did not support the addition of a pulsed dose of intravenous methylprednisolone to the conventional IVIG therapy for the primary treatment of KD. It remains to be seen whether other anti-inflammatory agents such as immunosuppressive therapies or new biologics will play a role in the management of patients with KD.
Gedalia
Abraham
A
Department of Pediatrics/Rheumatology, Children's Hospital, New Orleans, LA 70118, USA. a61543@pol.net
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D002675:Child, Preschool; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D011379:Prognosis; D044469:Racial Groups
D000305:Adrenal Cortex Hormones; D018501:Antirheumatic Agents; D016756:Immunoglobulins, Intravenous
J Pediatr. 1991 Aug;119(2):279-82
1861216
Arerugi. 1967 Mar;16(3):178-222
6062087
J Rheumatol. 2004 Apr;31(4):808-10
15088313
Pediatr Infect Dis J. 1999 May;18(5):451-5
10353519
J Pediatr. 2000 Aug;137(2):172-6
10931407
Clin Infect Dis. 1999 Feb;28(2):169-85; quiz 186-7
10064222
Am Fam Physician. 2006 Oct 1;74(7):1141-8
17039750
Pediatr Infect Dis J. 2000 Feb;19(2):91-4
10693992
J Immunol. 2001 Jan 15;166(2):1334-43
11145718
Pediatr Infect Dis J. 1996 Dec;15(12):1136-8
8970231
N Engl J Med. 2007 Feb 15;356(7):663-75
17301297
J Infect Dis. 1995 Aug;172(2):558-61
7622905
Circulation. 1993 May;87(5):1776-80
8491037
Pediatrics. 2003 Sep;112(3 Pt 1):495-501
12949272
Pediatr Infect Dis J. 1995 Jan;14(1):69-71
7715997
Curr Opin Pediatr. 2007 Feb;19(1):71-4
17224665
Pediatrics. 2004 Dec;114(6):1708-33
15574639
Lancet. 1993 Dec 4;342(8884):1385-8
7901681
Lancet. 1994 Jan 29;343(8892):300
7905129
Pediatr Infect Dis J. 1999 Jan;18(1):64-6
9951983
J Natl Med Assoc. 2008 Jan;100(1):28-32
18277805
Pediatr Cardiol. 2005 Nov-Dec;26(6):775-81
16421770
Am J Cardiol. 1998 May 1;81(9):1116-20
9605052
Pediatr Int. 2004 Oct;46(5):590-6
15491390
J Pediatr. 2005 May;146(5):662-7
15870671
Clin Pediatr (Phila). 2005 Oct;44(8):721-5
16211198
J Pediatr. 1996 Jan;128(1):146-9
8551407
Pediatrics. 1979 Feb;63(2):175-9
440805
J Infect Dis. 1990 Apr;161(4):680-4
2156943
N Engl J Med. 1991 Jun 6;324(23 ):1633-9
1709446
J Infect Dis. 2001 Oct 1;184(7):940-3
11528596
Circulation. 2006 Dec 12;114(24):2710-38
17130340
J Pediatr. 1993 Oct;123(4):657-9
8410524
J Infect Dis. 2006 Dec 15;194(12):1697-701
17109341
Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):576-81
12692003
Arch Dis Child. 2006 Oct;91(10):847-51
16990356
J Pediatr. 1999 Oct;135(4):465-9
10518080
Pediatr Int. 2005 Jun;47(3):305-10
15910456
J Pediatr. 2000 Aug;137(2):177-80
10931408
Jpn Circ J. 1982 Nov;46(11):1239-42
7131714
Pediatr Int. 2004 Feb;46(1):33-8
15043662
Lancet. 1994 Jul 2;344(8914):59
7912323
J Pediatr. 2006 Sep;149(3):336-341
16939743
J Pediatr. 2003 Jun;142(6):611-6
12838187
J Infect Dis. 1978 Jan;137(1):91-3
342638
Pediatrics. 1974 Sep;54(3):271-6
4153258